EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Long-Term Outcomes of Pediatric Intracardiac Masses: Clinical Course and Tumor Behavior in a Single-Center Experience

Şule Arıcı, Ahmed Mahmud Çırakoğlu, Figen Akalın

The European Research Journal · 01.08.2026 · 885-897

DOI: 10.18621/eurj.1220 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The European Research Journal, online erschienen am 01.08.2026. Verfasst von Şule Arıcı und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to evaluate the clinical characteristics, diagnostic pathways, echocardiographic and Holter findings, treatment strategies, and long-term outcomes of children with intracardiac masses, and to explore factors associated with tumor regression.

Methods

This retrospective observational study included children with echocardiographically confirmed intracardiac masses followed at a tertiary pediatric cardiology center between January 2010 and January 2022. Demographic and clinical characteristics, tumor features, serial echocardiographic measurements, 24-hour Holter recordings, treatment strategies, and follow-up outcomes were analyzed.

Results

A total of 20 patients were included. Rhabdomyoma was the most common tumor type (60%, n=12), followed by fibroma (30%, n=6). Most patients were asymptomatic or mildly symptomatic at presentation (90%, n=18). Clinically significant arrhythmias were observed in 15% (n=3), predominantly in patients with fibromas. Tumor size reduction was observed in 40% (n=8) of patients. All patients diagnosed during the fetal period (15%, n=3) exhibited tumor size reduction; all had rhabdomyomas. Everolimus was administered in 25% (n=5) of patients, with tumor size reduction observed in 80% (n=4) of treated cases; however, this was not statistically significant (P=0.253). Left ventricular systolic function remained preserved in all patients during follow-up.

Conclusion

Pediatric intracardiac masses are predominantly benign but show heterogeneous clinical behavior. Tumor regression was more frequent in rhabdomyomas; however, this may reflect tumor type distribution. Arrhythmias were more frequent in fibromas, supporting rhythm surveillance. Everolimus may be considered in selected patients; however, findings should be interpreted with caution due to limited sample size and potential selection bias, and require confirmation in larger studies.

Zitieren

APA

Arıcı, Ş., Çırakoğlu, A. M., & Akalın, F. (2026). Long-Term Outcomes of Pediatric Intracardiac Masses: Clinical Course and Tumor Behavior in a Single-Center Experience. The European Research Journal, 885-897. https://doi.org/10.18621/eurj.1220

Vancouver

Arıcı Ş, Çırakoğlu AM, Akalın F. Long-Term Outcomes of Pediatric Intracardiac Masses: Clinical Course and Tumor Behavior in a Single-Center Experience. The European Research Journal. 2026:885-897. doi:10.18621/eurj.1220

BibTeX
@article{Arc2026,
  author = {Arıcı, Şule and Çırakoğlu, Ahmed Mahmud and Akalın, Figen},
  title = {Long-Term Outcomes of Pediatric Intracardiac Masses: Clinical Course and Tumor Behavior in a Single-Center Experience},
  journal = {The European Research Journal},
  year = {2026},
  pages = {885--897},
  doi = {10.18621/eurj.1220}
}
Kostenlos starten →